Tuesday, Oct 3, 2023
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Science and Tech
  • Sport
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • Columns
    • Education Today
    • Reviews
    • Property
    • Videos
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • Columns
  • Reviews
  • Education Today
  • Property
  • Videos
  • Lifestyle
Home | Health | First Time In History Cancer Vanishes From Every Patients Body In Drug Trial

‘First time in history’: Cancer vanishes from every patient’s body in drug trial

New Delhi: In what appears to be a miracle and ‘first time in history’, a small clinical trial has found that every single rectal cancer patient who received an experimental treatment found that their cancer had vanished. According to New York Times, in the small clinical trial conducted by Memorial Sloan Kettering Cancer Center, 18 […]

By ANI
Updated On - 09:41 AM, Wed - 8 June 22
‘First time in history’: Cancer vanishes from every patient’s body in drug trial
Representational Image
whatsapp facebook twitter telegram

New Delhi: In what appears to be a miracle and ‘first time in history’, a small clinical trial has found that every single rectal cancer patient who received an experimental treatment found that their cancer had vanished.

According to New York Times, in the small clinical trial conducted by Memorial Sloan Kettering Cancer Center, 18 patients took a drug called Dostarlimab for around six months, and in the end, every one of them saw their tumours disappear.
Dr Luis A. Diaz J. of New York’s Memorial Sloan Kettering Cancer Center said this was “the first time this has happened in the history of cancer”.

According to experts, Dostarlimab is a drug with laboratory-produced molecules and it acts as substitute antibodies in the human body.

The cancer is undetectable by physical exam; endoscopy; positron emission tomography or PET scans or MRI scans, added Experts. This proves that Dostarlimab can be a ‘potential’ cure for one of the most deadly common cancers.

According to New York Times, patients involved in the clinical trial earlier underwent treatments such as chemotherapy, radiation, and invasive surgery that could result in bowel, urinary, and even sexual dysfunction. The 18 patients went into the trial expecting to have to go through these procedures as the next step. However, to their surprise, no further treatment was needed.

The findings of this trial have shocked experts and they have pointed out that complete remission in every single patient is “unheard-of”.

Dr Alan P. Venook, who is a colorectal cancer specialist at the University of California, said that the complete remission in every single patient is “unheard-of”. He hailed the research as a “world-first”.

Experts stated that the research was impressive as not all of the patients suffered significant complications from the drug trial.

“There were a lot of happy tears,” said Oncologist Dr Andrea Cercek, describing the moment patients found out they were cancer-free as quoted by New York Times.

According to doctors, the patients, during the trial, took Dostarlimab every three weeks for six months. “It is noteworthy that they were all in similar stages of their cancer. The cancer was locally advanced in the rectum but had not spread to other organs,” added doctors.

“At the time of this report, no patients had received chemoradiotherapy or undergone surgery, and no cases of progression or recurrence had been reported during follow-up,’ researchers wrote in the study published in the media outlet.
Cancer researchers who reviewed the drug told the media outlet that the treatment looks promising, but a larger-scale trial is needed.

Telangana Today Whatsapp
  • Follow Us :
  • Tags
  • Cancer
  • Dostarlimab
  • drug trial
  • Memorial Sloan Kettering Cancer Center

Related News

  • Editorial: Preventable tragedies

    Editorial: Preventable tragedies

  • About 70 pc of premature cancer deaths in 2020 preventable, 30 pc treatable: Lancet study

    About 70 pc of premature cancer deaths in 2020 preventable, 30 pc treatable: Lancet study

  • Scientists find genetic code behind rare kidney cancer

    Scientists find genetic code behind rare kidney cancer

  • Bariatric surgery linked to reduced hematological cancer risk: Study

    Bariatric surgery linked to reduced hematological cancer risk: Study

  • Study finds how bats evolved to avoid cancer

    Study finds how bats evolved to avoid cancer

  • Dental health may reduce head, neck cancer: Research

    Dental health may reduce head, neck cancer: Research

Latest News

  • Inflation in Pakistan rises to 31 pc in September

    6 mins ago
  • Modi tries to create rift between Southern-Northern States by accusing Congress

    9 mins ago
  • Congress responsible for death of Telangana protagonists: KTR

    10 mins ago
  • Manipur ethnic violence: Delhi court extends custody of accused by 8 days

    12 mins ago
  • Malla Reddy announces Rs 10 Lakh reward to Asian Games medalist Esha Singh

    10 mins ago
  • Uzbekistan’s Bukhara Medical University launches local office in Hyderabad

    24 mins ago
  • Fire breaks out at MP govt health centre in Datia district; no casualty

    27 mins ago
  • Seerat Kapoor to be seen in Telugu series ‘Save The Tigers 2’

    27 mins ago

company

  • Home
  • About Us
  • Contact Us

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

© Copyrights 2022 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam